Clinical Trial: A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine

U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06974565) titled 'A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine' on May 08.

Brief Summary: The purpose of this study is to assess the pharmacokinetics (PK) and safety of AZD2389 when administered alone and in combination with quinidine in healthy participants.

Study Start Date: May 12

Study Type: INTERVENTIONAL

Condition: Advanced Chronic Liver Disease Healthy Participants

Intervention: DRUG: AZD2389

AZD2389 will be administered orally.

DRUG: Quinidine

Quinidine will be administered orally.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca ...